Generated Narrative: CodeSystem med-clinical-category-cs

This case-sensitive code system https://nshr-uat.sha.go.ke/fhir/CodeSystem/med-clinical-category-cs defines the following codes:

CodeDisplayDefinition
CHEMOTHERAPY ChemotherapyCytotoxic agent used to kill or inhibit cancer cells.
IMMUNOTHERAPY ImmunotherapyAgent that stimulates the immune system against cancer.
TARGETED-THERAPY Targeted TherapyAgent targeting specific molecular markers on cancer cells.
HORMONAL-THERAPY Hormonal TherapyAgent that blocks or modifies hormone-driven tumour growth.
SUPPORTIVE-CARE Supportive CareMedication to manage side effects or improve tolerability.
ANTI-EMETIC Anti-emeticAgent to prevent or treat nausea and vomiting.
GROWTH-FACTOR Growth FactorColony-stimulating factor to support blood cell recovery.
CORTICOSTEROID CorticosteroidSteroid given as part of or to support the oncology regimen.
BISPHOSPHONATE BisphosphonateAgent for prevention or treatment of bone metastasis.
ANALGESIC AnalgesicPain management medication in the cancer care context.
 <status value="active"/> <experimental value="false"/> <date value="2026-06-04T14:49:30+00:00"/> <publisher value="Digital Health Agency (DHA), Kenya"/> <contact> <name value="Digital Health Agency (DHA), Kenya"/> <telecom> <system value="url"/> <value value="https://dha.go.ke"/> </telecom> <telecom> <system value="email"/> <value value="info@dha.go.ke"/> </telecom> </contact> <contact> <name value="Digital Health Agency Kenya – FHIR Team"/> <telecom> <system value="email"/> <value value="info@dha.go.ke"/> <use value="work"/> </telecom> <telecom> <system value="url"/> <value value="https://dha.go.ke"/> <use value="work"/> </telecom> </contact> <description value="Codes classifying the clinical role of a medication within an oncology regimen."/> <jurisdiction> <coding> <system value="urn:iso:std:iso:3166"/> <code value="KE"/> <display value="Kenya"/> </coding> </jurisdiction> <caseSensitive value="true"/> <content value="complete"/> <count value="10"/> <concept> <code value="CHEMOTHERAPY"/> <display value="Chemotherapy"/> <definition value="Cytotoxic agent used to kill or inhibit cancer cells."/> </concept> <concept> <code value="IMMUNOTHERAPY"/> <display value="Immunotherapy"/> <definition value="Agent that stimulates the immune system against cancer."/> </concept> <concept> <code value="TARGETED-THERAPY"/> <display value="Targeted Therapy"/> <definition value="Agent targeting specific molecular markers on cancer cells."/> </concept> <concept> <code value="HORMONAL-THERAPY"/> <display value="Hormonal Therapy"/> <definition value="Agent that blocks or modifies hormone-driven tumour growth."/> </concept> <concept> <code value="SUPPORTIVE-CARE"/> <display value="Supportive Care"/> <definition value="Medication to manage side effects or improve tolerability."/> </concept> <concept> <code value="ANTI-EMETIC"/> <display value="Anti-emetic"/> <definition value="Agent to prevent or treat nausea and vomiting."/> </concept> <concept> <code value="GROWTH-FACTOR"/> <display value="Growth Factor"/> <definition value="Colony-stimulating factor to support blood cell recovery."/> </concept> <concept> <code value="CORTICOSTEROID"/> <display value="Corticosteroid"/> <definition value="Steroid given as part of or to support the oncology regimen."/> </concept> <concept> <code value="BISPHOSPHONATE"/> <display value="Bisphosphonate"/> <definition value="Agent for prevention or treatment of bone metastasis."/> </concept> <concept> <code value="ANALGESIC"/> <display value="Analgesic"/> <definition value="Pain management medication in the cancer care context."/> </concept> </CodeSystem>